Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Marcelo C PasquiniDaniel Weisdorf

Abstract

The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. MK+ AML was associated with higher disease relapse (hazard ratio, 1.98; P < .01), similar transplantation-related mortality (TRM) (hazard ratio, 1.01; P = .90), and worse survival (hazard ratio, 1.67; P < .01) compared with those outcomes for other cytogenetically defined AML. Among patients with MDS, MK+ MDS was associated with higher disease relapse (hazard ratio, 2.39; P < .01), higher TRM (hazard ratio, 1.80; P < .01), and worse survival (HR, 2.02; P < .01). Subset analyses comparing chromosome 7 abnormalities (del7/7q) with or without MK+ demonstrated higher mortality for MK+ disease in for both AML (hazard ratio, 1.72; P < .01) and MDS (hazard ratio, 1.79; P < .01). The strong negative impact of MK+ in myeloid malignancies was observed in all age groups and using either myeloabla...Continue Reading

References

Sep 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Elaine M SloandNeal S Young
Aug 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Feb 11, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sergio GiraltBrenda Sandmaier
Jun 18, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Betul OranDaniel Weisdorf
Aug 4, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Philippe ArmandDaniel J Weisdorf
Jan 12, 2012·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Massimo PasquiniMassimo Biondi
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie SchanzDetlef Haase
May 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan J CornelissenBob Löwenberg
Mar 6, 2013·American Journal of Hematology·Elise Boudry-LabisUNKNOWN French ALFA group
Jun 13, 2013·American Journal of Hematology·Thomas CluzeauJill-Patrice Cassuto
Jun 22, 2013·Leukemia·J SchanzD Haase
Feb 22, 2014·Blood·Matteo G Della PortaUNKNOWN Gruppo Italiano Trapianto di Midollo Osseo
Jan 27, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Celalettin UstunErica D Warlick

❮ Previous
Next ❯

Citations

Nov 29, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Julie Schanz
Aug 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marlise R LuskinRan Reshef
Jun 28, 2017·British Journal of Haematology·Michael Medinger, Jakob R Passweg
Mar 4, 2020·Current Hematologic Malignancy Reports·Nathalie Danielson, Michael Byrne
Apr 29, 2020·Pharmacotherapy·Kathryn A CulosMichael Byrne
Aug 21, 2021·Frontiers in Immunology·Roberto LimongelloAntonio Pierini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Fausto R LoberizaNavneet S Majhail
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Feng ChengSuning Chen
© 2021 Meta ULC. All rights reserved